Dinutuximab Beta as a theragnostic vector for non-invasive molecular imaging and radiotherapy of high-risk neuroblastoma

Project: Research

Project Details

Acronymdinutuximab
StatusFinished
Effective start/end date1/04/2022 → 31/03/2025

Collaborative partners

  • King's College London
  • Queen Mary University of London
  • ROYAL MARSDEN NHS FOUNDATION TRUST
  • University College London (lead)

Funding

  • Neuroblastoma UK: £30,000.00